Therefore, it would be worthwhile to monitor the dynamic process of sHLA-G and cytokines in patients with cervical cancer and explore anti-HLA-G-based immunotherapy strategies for breaking down tolerance in cancer (Paradkar et al. 2014; Gimenes et al. 2014). This evidence concerns the gene HLA-G and cancer.